Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Optibrium and AstraZeneca sign agreement for global license of StarDrop
October 2013
by Bruce Poorman  |  Email the author
SHARING OPTIONS:


 
Optibrium Ltd.
 
Optibrium, a developer of software for drug discovery, today announced that AstraZeneca has signed an agreement to license Optibrium's StarDrop software.  The agreement will see the global deployment of StarDrop and the ADME-QSAR and Auto-Modeller modules to AstraZeneca's researchers. StarDrop is a software suite that helps to deliver optimally balanced, effective drugs. By quickly highlighting diverse, high-quality compounds, StarDrop dramatically reduces the time it takes to find effective leads and then transform them into candidate drugs, which will have a high probability of success downstream.
 
Optibrium Ltd.
www.optibrium.com   
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.